U.S. flag

An official website of the United States government

NM_000535.7(PMS2):c.706-4del AND Hereditary cancer-predisposing syndrome

Germline classification:
Benign (2 submissions)
Last evaluated:
Oct 6, 2021
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000564416.7

Allele description [Variation Report for NM_000535.7(PMS2):c.706-4del]

NM_000535.7(PMS2):c.706-4del

Gene:
PMS2:PMS1 homolog 2, mismatch repair system component [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
7p22.1
Genomic location:
Preferred name:
NM_000535.7(PMS2):c.706-4del
HGVS:
  • NC_000007.13:g.6037058del
  • NC_000007.14:g.5997443del
  • NG_008466.1:g.16680del
  • NM_000535.7:c.706-4delMANE SELECT
  • NM_001322003.2:c.301-4del
  • NM_001322004.2:c.301-4del
  • NM_001322005.2:c.301-4del
  • NM_001322006.2:c.706-4del
  • NM_001322007.2:c.388-4del
  • NM_001322008.2:c.388-4del
  • NM_001322009.2:c.301-4del
  • NM_001322010.2:c.301-4del
  • NM_001322011.2:c.-228-4del
  • NM_001322012.2:c.-228-4del
  • NM_001322013.2:c.133-4del
  • NM_001322014.2:c.706-4del
  • NM_001322015.2:c.397-4del
  • LRG_161t1:c.706-4del
  • LRG_161:g.16680del
  • NC_000007.13:g.6037058del
  • NC_000007.13:g.6037058delA
  • NC_000007.13:g.6037074del
  • NM_000535.5:c.706-4del
  • NM_000535.5:c.706-4delT
  • NM_000535.5:c.706-5delT
  • NM_000535.6:c.706-4delT
  • NM_000535.6:c.706-5del
  • NM_000535.6:c.706-5delT
  • NM_000535.5:c.706-4delT
Links:
Ambry Genetics: a02961; dbSNP: rs60794673
NCBI 1000 Genomes Browser:
rs60794673
Molecular consequence:
  • NM_000535.7:c.706-4del - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001322003.2:c.301-4del - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001322004.2:c.301-4del - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001322005.2:c.301-4del - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001322006.2:c.706-4del - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001322007.2:c.388-4del - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001322008.2:c.388-4del - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001322009.2:c.301-4del - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001322010.2:c.301-4del - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001322011.2:c.-228-4del - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001322012.2:c.-228-4del - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001322013.2:c.133-4del - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001322014.2:c.706-4del - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001322015.2:c.397-4del - intron variant - [Sequence Ontology: SO:0001627]
Observations:
1

Condition(s)

Name:
Hereditary cancer-predisposing syndrome
Synonyms:
Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0015356; MeSH: D009386; MedGen: C0027672

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000663426Ambry Genetics
criteria provided, single submitter

(Ambry Autosomal Dominant and X-Linked criteria (3/2017))
Benign
(May 18, 2017)
germlineclinical testing

Citation Link,

SCV000691102Color Diagnostics, LLC DBA Color Health
criteria provided, single submitter

(ACMG Guidelines, 2015)
Benign
(Oct 6, 2021)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknown1not providednot provided1not providedclinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From Ambry Genetics, SCV000663426.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testingnot provided

Description

General population or subpopulation frequency is too high to be a pathogenic mutation based on disease/syndrome prevalence and penetrance

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknown1not providednot provided1not providednot providednot provided

From Color Diagnostics, LLC DBA Color Health, SCV000691102.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024